Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4
E. Scott Priestley(Bristol-Myers Squibb (United States)), Anne Marinier(Institute for Research in Immunology and Cancer), Ruth R. Wexler(DuPont (United States)), Edward H. Ruediger(Institute for Research in Immunology and Cancer), Anuradha Gupta(Bristol-Myers Squibb (India)), Julia Guy(Institute for Research in Immunology and Cancer), Arvind Mathur(Bristol-Myers Squibb (United States)), Pancras C. Wong(Bristol-Myers Squibb (United States)), Jeremy M. Richter(Bristol-Myers Squibb (Germany)), Roger Rémillard(Institute for Research in Immunology and Cancer), Muthalagu Vetrichelvan(Bristol-Myers Squibb (India)), Victor R. Guarino(Bristol-Myers Squibb (United States)), Shana Posy(Bristol-Myers Squibb (United States)), Alain Martel(Institute for Research in Immunology and Cancer), Chi Shing Sum(Bristol-Myers Squibb (United States)), Jing Yang(Bristol-Myers Squibb (United States)), François Tremblay(Institute for Research in Immunology and Cancer), T. J. Balapragalathan(Bristol-Myers Squibb (India)), Daniel H. Deon(Institute for Research in Immunology and Cancer), Serge Plamondon(Institute for Research in Immunology and Cancer), Mary Ellen Cvijic(Bristol-Myers Squibb (United States)), Michel Bouvier(University of California, San Francisco), Carol A. Watson(Bristol-Myers Squibb (United States)), Jianqing Li(Bristol-Myers Squibb (United States)), Ji Hua(Bristol-Myers Squibb (United States)), David A. Gordon(Bristol-Myers Squibb (United States)), Marc Gagnon(Institute for Research in Immunology and Cancer), Jocelyne Guay(Institute for Research in Immunology and Cancer), Mario Callejo(Institute for Research in Immunology and Cancer), Jean-François Lavallée(Institute for Research in Immunology and Cancer), Laurence Dubé(Institute for Research in Immunology and Cancer), Philippe Lapointe(Institute for Research in Immunology and Cancer), Jacques Banville(Institute for Research in Immunology and Cancer)
Cited by 27
Related Papers
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
|Journal of Clinical Investigation|2000|561
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
|Bioorganic & Medicinal Chemistry Letters|1998|406
Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinones<i>via</i>a Redox Economic Approach
|Journal of the American Chemical Society|2008|283
Enantioselective Total Syntheses of Welwitindolinone A and Fischerindoles I and G
|Journal of the American Chemical Society|2005|273